IMPORTANCE: Pathophysiologic mechanisms leading to loss of white matter integrity and the temporal positioning of biomarkers of white matter integrity relative to the biomarkers of gray matter neurodegeneration and amyloid load in the course of Alzheimer disease (AD) are poorly understood. OBJECTIVE: To investigate the effects of AD-related gray matter neurodegeneration and high β-amyloid on white matter microstructure in older adults without dementia. DESIGN, SETTING, AND PARTICIPANTS: A population-based, longitudinal cohort study was conducted. Participants included in the Mayo Clinic Study of Aging (N = 701) who underwent magnetic resonance imaging, diffusion tensor imaging (DTI), and positron emission tomography studies with diagnoses of cognitively normal ([CN] n = 570) or mild cognitive impairment ([MCI] n = 131) were included. Both groups were divided into biomarker-negative, amyloid-positive-only, neurodegeneration-positive-only, and amyloid plus neurodegeneration-positive groups based on their amyloid load shown on carbon 11-labeled Pittsburgh Compound B positron emission tomography, AD hypometabolic pattern shown on fludeoxyglucose F 18 positron emission tomography, and/or hippocampal atrophy shown on magnetic resonance imaging. MAIN OUTCOMES AND MEASURES: Fractional anisotropy (FA) determined using DTI. RESULTS: No FA alterations were observed in biomarker-negative MCI and amyloid-positive-only CN and MCI groups compared with biomarker-negative CN participants on voxel-based analysis (P < .05; familywise error corrected). Conversely, the neurodegeneration-positive-only and amyloid plus neurodegeneration-positive CN and MCI groups consistently had decreased FA in the fornix, which correlated with cognitive performance (ρ = 0.38; P < .001). Patients with MCI had more extensive white matter involvement than did those with CN, and the greatest FA decreases were observed in the amyloid plus neurodegeneration-positive MCI group (P < .05; familywise error corrected). CONCLUSIONS AND RELEVANCE: A high amyloid load does not influence diffusion tensor imaging-based measures of white matter integrity in the absence of coexistent gray matter neurodegeneration in older adults without dementia.
IMPORTANCE: Pathophysiologic mechanisms leading to loss of white matter integrity and the temporal positioning of biomarkers of white matter integrity relative to the biomarkers of gray matter neurodegeneration and amyloid load in the course of Alzheimer disease (AD) are poorly understood. OBJECTIVE: To investigate the effects of AD-related gray matter neurodegeneration and high β-amyloid on white matter microstructure in older adults without dementia. DESIGN, SETTING, AND PARTICIPANTS: A population-based, longitudinal cohort study was conducted. Participants included in the Mayo Clinic Study of Aging (N = 701) who underwent magnetic resonance imaging, diffusion tensor imaging (DTI), and positron emission tomography studies with diagnoses of cognitively normal ([CN] n = 570) or mild cognitive impairment ([MCI] n = 131) were included. Both groups were divided into biomarker-negative, amyloid-positive-only, neurodegeneration-positive-only, and amyloid plus neurodegeneration-positive groups based on their amyloid load shown on carbon 11-labeled Pittsburgh Compound B positron emission tomography, AD hypometabolic pattern shown on fludeoxyglucose F 18 positron emission tomography, and/or hippocampal atrophy shown on magnetic resonance imaging. MAIN OUTCOMES AND MEASURES: Fractional anisotropy (FA) determined using DTI. RESULTS: No FA alterations were observed in biomarker-negative MCI and amyloid-positive-only CN and MCI groups compared with biomarker-negative CN participants on voxel-based analysis (P < .05; familywise error corrected). Conversely, the neurodegeneration-positive-only and amyloid plus neurodegeneration-positive CN and MCI groups consistently had decreased FA in the fornix, which correlated with cognitive performance (ρ = 0.38; P < .001). Patients with MCI had more extensive white matter involvement than did those with CN, and the greatest FA decreases were observed in the amyloid plus neurodegeneration-positive MCI group (P < .05; familywise error corrected). CONCLUSIONS AND RELEVANCE: A high amyloid load does not influence diffusion tensor imaging-based measures of white matter integrity in the absence of coexistent gray matter neurodegeneration in older adults without dementia.
Authors: Sylvia Villeneuve; Bruce R Reed; Miranka Wirth; Claudia M Haase; Cindee M Madison; Nagehan Ayakta; Wendy Mack; Dan Mungas; Helena C Chui; Charles DeCarli; Michael W Weiner; William J Jagust Journal: Neurology Date: 2014-01-31 Impact factor: 9.910
Authors: Liang Zhan; Neda Jahanshad; Daniel B Ennis; Yan Jin; Matthew A Bernstein; Bret J Borowski; Clifford R Jack; Arthur W Toga; Alex D Leow; Paul M Thompson Journal: Hum Brain Mapp Date: 2012-04-21 Impact factor: 5.038
Authors: Victor L Villemagne; Samantha Burnham; Pierrick Bourgeat; Belinda Brown; Kathryn A Ellis; Olivier Salvado; Cassandra Szoeke; S Lance Macaulay; Ralph Martins; Paul Maruff; David Ames; Christopher C Rowe; Colin L Masters Journal: Lancet Neurol Date: 2013-03-08 Impact factor: 44.182
Authors: Susan M Landau; Mark A Mintun; Abhinay D Joshi; Robert A Koeppe; Ronald C Petersen; Paul S Aisen; Michael W Weiner; William J Jagust Journal: Ann Neurol Date: 2012-10 Impact factor: 10.422
Authors: Clifford R Jack; Heather J Wiste; Stephen D Weigand; David S Knopman; Val Lowe; Prashanthi Vemuri; Michelle M Mielke; David T Jones; Matthew L Senjem; Jeffrey L Gunter; Brian E Gregg; Vernon S Pankratz; Ronald C Petersen Journal: Neurology Date: 2013-10-16 Impact factor: 9.910
Authors: Yu Zhang; Norbert Schuff; Monica Camacho; Linda L Chao; Thomas P Fletcher; Kristine Yaffe; Susan C Woolley; Catherine Madison; Howard J Rosen; Bruce L Miller; Michael W Weiner Journal: PLoS One Date: 2013-06-06 Impact factor: 3.240
Authors: Joshua Z Willey; Yeseon P Moon; Mandip S Dhamoon; Erin R Kulick; Ahmet Bagci; Noam Alperin; Ying Kuen Cheung; Clinton B Wright; Ralph L Sacco; Mitchell S V Elkind Journal: Neuroepidemiology Date: 2018-06-28 Impact factor: 3.282
Authors: Jennifer S Rabin; Rodrigo D Perea; Rachel F Buckley; Taylor E Neal; Randy L Buckner; Keith A Johnson; Reisa A Sperling; Trey Hedden Journal: Cereb Cortex Date: 2019-03-01 Impact factor: 5.357
Authors: Jennifer S Rabin; Rodrigo D Perea; Rachel F Buckley; Keith A Johnson; Reisa A Sperling; Trey Hedden Journal: Neurobiol Aging Date: 2019-05-16 Impact factor: 4.673
Authors: Christine L Tardif; Gabriel A Devenyi; Robert S C Amaral; Sandra Pelleieux; Judes Poirier; Pedro Rosa-Neto; John Breitner; M Mallar Chakravarty Journal: Hum Brain Mapp Date: 2017-11-21 Impact factor: 5.038
Authors: Kejal Kantarci; Melissa E Murray; Christopher G Schwarz; Robert I Reid; Scott A Przybelski; Timothy Lesnick; Samantha M Zuk; Mekala R Raman; Matthew L Senjem; Jeffrey L Gunter; Bradley F Boeve; David S Knopman; Joseph E Parisi; Ronald C Petersen; Clifford R Jack; Dennis W Dickson Journal: Neurobiol Aging Date: 2017-05-04 Impact factor: 4.673
Authors: Farshid Sepehrband; Ryan P Cabeen; Jeiran Choupan; Giuseppe Barisano; Meng Law; Arthur W Toga Journal: Neuroimage Date: 2019-04-30 Impact factor: 6.556
Authors: Vijay K Ramanan; Scott A Przybelski; Jonathan Graff-Radford; Anna M Castillo; Val J Lowe; Michelle M Mielke; Rosebud O Roberts; Robert I Reid; David S Knopman; Clifford R Jack; Ronald C Petersen; Prashanthi Vemuri Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Anna Rieckmann; Koene R A Van Dijk; Reisa A Sperling; Keith A Johnson; Randy L Buckner; Trey Hedden Journal: Neurobiol Aging Date: 2016-03-21 Impact factor: 4.673
Authors: Jian W Dong; Ileana O Jelescu; Benjamin Ades-Aron; Dmitry S Novikov; Kent Friedman; James S Babb; Ricardo S Osorio; James E Galvin; Timothy M Shepherd; Els Fieremans Journal: Neurobiol Aging Date: 2020-01-23 Impact factor: 4.673